Two candidates at the heart of dysfunction: The ryanodine receptor and calcium/calmodulin protein kinase II as potential targets for therapeutic intervention—An in vivo perspective-Reference-Cited by-同舟云学术

Two candidates at the heart of dysfunction: The ryanodine receptor and calcium/calmodulin protein kinase II as potential targets for therapeutic intervention—An in vivo perspective

Published:2011-08 Issue:2 Volume:131 Page:204-220
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Currie Susan,Elliott Elspeth B.,Smith Godfrey L.,Loughrey Christopher M.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference164 articles.

1. Nifedipine inhibits cardiac hypertrophy and left ventricular dysfunction in response to pressure overload;Ago;J Cardiovasc Trans Res,2010

2. CaM kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure;Ai;Circ Res,2005

3. Multiple downstream proarrhythmic targets for calmodulin kinase II: moving beyond an ion channel-centric focus;Anderson;Cardiovasc Res,2007

4. CaMKII and a failing strategy for growth in heart;Anderson;J Clin Invest,2009

5. Multifunctional Ca2+/calmodulin-dependent protein kinase mediates Ca2+−induced enhancement of the L-type Ca2+ current in rabbit ventricular myocytes;Anderson;Circ Res,1994

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing myocardial function with cardiac contractility modulation: potential and challenges;ESC Heart Failure;2023-11-10

2. Ca 2+ mishandling in heart failure: Potential targets;Acta Physiologica;2021-06-06

3. New Targets in Heart Failure Drug Therapy;Frontiers in Cardiovascular Medicine;2021-05-05

4. Future Therapies in HFpEF;Diastology;2021

5. Regulation of JNK signaling pathway and RIPK3/AIF in necroptosis-mediated global cerebral ischemia/reperfusion injury in rats;Experimental Neurology;2020-09